Beam Therapeutics Inc.BEAMNASDAQ
Loading
Debt to Assets Over TimeNormalizing
Percentile Rank63
3Y CAGR+14.1%
5Y CAGR-3.6%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
+14.1%/yr
Annual compound
5Y CAGR
-3.6%/yr
Recent acceleration
Percentile
P63
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive growthNormalizing
PeriodValueYoY Change
20250.20+35.7%
20240.15+23.6%
20230.12-11.3%
20220.13+33.2%
20210.10-58.0%
20200.24+19.1%
20190.20-
20180.00-100.0%
20170.42-